BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 20214847)

  • 21. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study.
    Stern Y; Albert M; Brandt J; Jacobs DM; Tang MX; Marder K; Bell K; Sano M; Devanand DP; Bylsma F
    Neurology; 1994 Dec; 44(12):2300-7. PubMed ID: 7991116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease.
    Nielsen AB; Siersma V; Waldemar G; Waldorff FB
    BMC Geriatr; 2016 Apr; 16():87. PubMed ID: 27094158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosis of Alzheimer's disease: clinical characteristics and history.
    Schneider LS; Dagerman KS
    J Psychiatr Res; 2004 Jan; 38(1):105-11. PubMed ID: 14690773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.
    Reed C; Belger M; Vellas B; Andrews JS; Argimon JM; Bruno G; Dodel R; Jones RW; Wimo A; Haro JM
    Int Psychogeriatr; 2016 Feb; 28(2):247-59. PubMed ID: 26307191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
    Lopez OL; Becker JT; Saxton J; Sweet RA; Klunk W; DeKosky ST
    J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease.
    Rosenheck RA; Leslie DL; Sindelar JL; Miller EA; Tariot PN; Dagerman KS; Davis SM; Lebowitz BD; Rabins P; Hsiao JK; Lieberman JA; Schneider LS;
    Arch Gen Psychiatry; 2007 Nov; 64(11):1259-68. PubMed ID: 17984395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supervised exercise to reduce agitation in severely cognitively impaired persons.
    Aman E; Thomas DR
    J Am Med Dir Assoc; 2009 May; 10(4):271-6. PubMed ID: 19426944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of nursing home admission in association with mental illness nationally in the Department of Veterans Affairs.
    Miller EA; Rosenheck RA
    Med Care; 2006 Apr; 44(4):343-51. PubMed ID: 16565635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.
    Aarsland D; Larsen JP; Tandberg E; Laake K
    J Am Geriatr Soc; 2000 Aug; 48(8):938-42. PubMed ID: 10968298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive Aging Trajectories and Burdens of Disability, Hospitalization and Nursing Home Admission Among Community-living Older Persons.
    Han L; Gill TM; Jones BL; Allore HG
    J Gerontol A Biol Sci Med Sci; 2016 Jun; 71(6):766-71. PubMed ID: 26511011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The course of neuropsychiatric symptoms in nursing home residents from admission to 30-month follow-up.
    Helvik AS; Selbæk G; Šaltytė Benth J; Røen I; Bergh S
    PLoS One; 2018; 13(10):e0206147. PubMed ID: 30335840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: the CATIE-AD study.
    Miller EA; Rosenheck RA; Schneider LS
    Curr Alzheimer Res; 2010 Jun; 7(4):348-57. PubMed ID: 19715552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidity of psychopathological domains in community-dwelling persons with Alzheimer's disease.
    Tractenberg RE; Weiner MF; Patterson MB; Teri L; Thal LJ
    J Geriatr Psychiatry Neurol; 2003 Jun; 16(2):94-9. PubMed ID: 12801159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial.
    Rolland Y; Pillard F; Klapouszczak A; Reynish E; Thomas D; Andrieu S; Rivière D; Vellas B
    J Am Geriatr Soc; 2007 Feb; 55(2):158-65. PubMed ID: 17302650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting nursing home admission in the U.S: a meta-analysis.
    Gaugler JE; Duval S; Anderson KA; Kane RL
    BMC Geriatr; 2007 Jun; 7():13. PubMed ID: 17578574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity and responsiveness of the Minimum Data Set.
    Snowden M; McCormick W; Russo J; Srebnik D; Comtois K; Bowen J; Teri L; Larson EB
    J Am Geriatr Soc; 1999 Aug; 47(8):1000-4. PubMed ID: 10443863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unmet visual needs of Alzheimer's disease patients in long-term care facilities.
    Koch JM; Datta G; Makhdoom S; Grossberg GT
    J Am Med Dir Assoc; 2005; 6(4):233-7. PubMed ID: 16005408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
    Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient and caregiver characteristics and nursing home placement in patients with dementia.
    Yaffe K; Fox P; Newcomer R; Sands L; Lindquist K; Dane K; Covinsky KE
    JAMA; 2002 Apr; 287(16):2090-7. PubMed ID: 11966383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.
    Nagata T; Nakajima S; Shinagawa S; Plitman E; Nakayama K; Graff-Guerrero A; Mimura M
    J Alzheimers Dis; 2017; 60(1):263-272. PubMed ID: 28800334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.